Ipsogen Announces 3 Studies At ASCO Meeting Extending The Utility Of The Genomic Grade Index For...

                   
medicalnewstoday.com     May 20, 2008            

IPSOGEN SA (Marseille and New Haven), a cancer profiler that develops and markets molecular diagnostic assays for blood & breast cancers, announced that researchers from the University of Texas MD Anderson Cancer Center (MDACC, Houston, TX) will present the results of two studies on the Genomic... [read full story]                

Full Coverage
                   

Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting...

prnewswire.com     May 19, 2008          

Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer MARSEILLE, France, May 19 /PRNewswire/ -- IPSOGEN SA (Marseille and New Haven), a cancer profiler...                

comments